Nicholas Pajewski to Prevalence
This is a "connection" page, showing publications Nicholas Pajewski has written about Prevalence.
Connection Strength
0.319
-
Pajewski NM, Lenoir K, Wells BJ, Williamson JD, Callahan KE. Frailty Screening Using the Electronic Health Record Within a Medicare Accountable Care Organization. J Gerontol A Biol Sci Med Sci. 2019 10 04; 74(11):1771-1777.
Score: 0.138
-
Gower EW, Stein JD, Shekhawat NS, Mikkilineni S, Blachley TS, Pajewski NM. Geographic and Demographic Variation in Use of Ranibizumab Versus Bevacizumab for Neovascular Age-related Macular Degeneration in the United States. Am J Ophthalmol. 2017 Dec; 184:157-166.
Score: 0.121
-
Marcum ZA, Cohen JB, Zhang C, Derington CG, Greene TH, Ghazi L, Herrick JS, King JB, Cheung AK, Bryan N, Supiano MA, Sonnen JA, Weintraub WS, Williamson J, Pajewski NM, Bress AP. Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment. JAMA Netw Open. 2022 01 04; 5(1):e2145319.
Score: 0.040
-
Fontaine KR, McCubrey R, Mehta T, Pajewski NM, Keith SW, Bangalore SS, Crespo CJ, Allison DB. Body mass index and mortality rate among Hispanic adults: a pooled analysis of multiple epidemiologic data sets. Int J Obes (Lond). 2012 Aug; 36(8):1121-6.
Score: 0.020